Workflow
Bristol Myers Squibb to Participate in Upcoming Investor Conferences
BMYBristol-Myers Squibb(BMY) Businesswire·2024-03-07 05:17

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in two upcoming investor conferences in March 2024. Samit Hirawat, M.D., executive vice president, chief medical officer, Drug Development, will take part in a fireside chat at the Leerink Partners Global Biopharma Conference 2024 in Miami Beach, Florida, on Wednesday, March 13, 2024. He will answer questions about the company beginning at 10:00 a.m. ET. Lynelle Hoch, president, Cell Therap ...